Slowly Progressive Type 1 Diabetes Treated with Metformin for Five Years after Onset-Reference-Cited by-同舟云学术

Slowly Progressive Type 1 Diabetes Treated with Metformin for Five Years after Onset

Published:2013 Issue:23 Volume:52 Page:2635-2637
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hirata Takumi¹²,Shimada Akira³,Morimoto Jiro¹,Maruyama Taro¹

Affiliation:

1. Department of Internal Medicine, Saitama Social Insurance Hospital, Japan

2. Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, Japan

3. Department of Internal Medicine, Saiseikai Central Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/52/23/52_52.9522/_pdf

Reference19 articles.

1. 1. Zimmet PZ. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography. Diabetes Care 18: 1050-1064, 1995.

2. 2. Naik RG, Brooks-Worrell BM, Palmer JP. Latent autoimmune diabetes in adults. J Clin Endocrinol 94: 4635-4644, 2009.

3. 3. Kobayashi T, Tamemoto K, Nakanishi K, et al. Immunogenic and clinical characterization of slowly progressive IDDM. Diabetes Care 16: 780-788, 1993.

4. 4. van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 25: 117-125, 2008.

5. 5. Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11: 299-303, 1994.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives

;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2019-11

2. Distinct Inflammatory Changes of the Pancreas of Slowly Progressive Insulin-dependent (Type 1) Diabetes;Pancreas;2018-10

3. Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S);Diabetes Therapy;2017-09-19